Journal article
Interleukin-6 gene promoter-572 C allele may play a role in rate of disease progression in multiple sclerosis
J Yan, J Liu, CY Lin, RJ Scott, J Lechner-Scott, DR Booth, GJ Stewart, S Broadley, D Mason, L Griffiths, P Moscato, M Slee, B Taylor, J Wiley, J Field, H Butzkueven, TJ Kilpatrick, PA Csurhes, MP Pender, PA McCombe Show all
International Journal of Molecular Sciences | MDPI AG | Published : 2012
Abstract
Multiple sclerosis (MS) is an inflammatory demyelinating disease affecting the central nervous system. Although the exact pathogenesis of MS is unknown, it is generally considered to be an autoimmune disease, with numerous genetic and environmental factors determining disease susceptibility and severity. One important mediator of immune responses and inflammation is interleukin-6 (IL-6). Previously, elevated levels of IL-6 in mononuclear cells in blood and in brain tissue from MS patients have been reported. Various polymorphisms in the promoter region of the IL6 gene have also been linked with IL-6 protein levels. In MS, several small studies have investigated whether two IL6 promoter polym..
View full abstractRelated Projects (2)
Grants
Funding Acknowledgements
Financial support for this project was provided by MS Research Australia and the Royal Brisbane and Women's Hospital Research Foundation.